Latest stories on AQST
Aquestive Therapeutics, Inc. (AQST) files 8-K
SEC 8-K50 · neutralgeneral
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
StockTitan63 · neutralproduct/pr
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
GlobeNewswire67 · bullishproduct/pr
Aquestive Therapeutics (AQST): Second Chance At Anaphylm Comes Into Focus
Yahoo Top58 · neutralproduct/pr
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
Business Insider56 · neutralgeneral
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire56 · neutralgeneral
Aquestive Therapeutics: Potential Catalyst On The Horizon
Seeking Alpha63 · neutralproduct/pr
Aquestive (AQST) Q2 2026 Earnings Call Transcript
Yahoo Top67 · bullishearnings
Aquestive (AQST) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Aquestive targets Q3 NDA resubmission for Anaphylm while maintaining 2026 revenue guidance of $46M-$50M
Seeking Alpha58 · neutralproduct/pr
Aquestive Therapeutics, Inc. (AQST) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Aquestive Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Aquestive Therapeutics Q2 Earnings Call Highlights
Yahoo Top56 · neutralearnings
Aquestive Therapeutics, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Aquestive Therapeutics backs FY26 revenue view $46M-$50M, consensus $50.51M
The Fly52 · neutralearnings
Aquestive Therapeutics reports Q2 EPS (18c), consensus (12c)
The Fly42 · neutralearnings
Aquestive Therapeutics, Inc. (AQST) files 8-K
SEC 8-K50 · neutralgeneral
Aquestive Therapeutics GAAP EPS of -$0.18 misses by $0.08, revenue of $13.82M beats by $2.26M
Seeking Alpha34 · bearishearnings
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan34 · bearishearnings
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire34 · bearishearnings
Aquestive Therapeutics Options Imply 6 1 Move In Share Price Post Earnings
The Fly56 · neutralearnings
Aquestive Therapeutics' Updated Anaphylm Film Shows Strong Progress in Human Factors and PK Studies
August 11, 2026
MarketChameleon67 · bullishproduct/pr
Aquestive Therapeutics Shares Rise After Positive Topline Results for Anaphylm Sublingual Film
Morningstar67 · bullishproduct/pr
Anaphylm Study Results Mark Major Progress for Aquestive: Human Factors Redesign Cuts Opening Time by 82%, Improves User Safety
August 10, 2026
MarketChameleon67 · bullishproduct/pr
Aquestive Therapeutics shares jump after encouraging Anaphylm study results
InvestorsHub67 · bullishproduct/pr